je.st
news
Tag: liver
Eli Lilly cancer drug comes up short in liver cancer trial
2015-06-20 22:02:14| Food - Topix.net
Eli Lilly cancer drug comes up short in liver cancer trial But Cyramza shows promise in liver cancer patients with tumor-produced proteins. Check out this story on IndyStar.com: http://indy.st/1MSJIQb Eli Lilly and Co.'
Eli Lilly cancer drug comes up short in liver cancer trial
2015-06-20 00:20:10| Agriculture - Topix.net
Eli Lilly cancer drug comes up short in liver cancer trial But Cyramza shows promise in liver cancer patients with tumor-produced proteins. Check out this story on IndyStar.com: http://indy.st/1MSJIQb Eli Lilly and Co.'
Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW
2015-05-19 09:30:24| Biotech - Topix.net
Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application with the U.K. Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease . As per the CTA filing, the intended clinical study of ALN-AAT will be performed in normal healthy volunteers, and, then, in subjects with alpha-1 liver disease.
Tags: data
application
files
trial
Merck Announces Presentation of Phase 2 Clinical Trial Results of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir at the International Liver CongressTM 2015
2015-04-25 15:00:00| Merck.com - Corporate News
Dateline City: VIENNA Results of C-SALVAGE Study Showed High Sustained Virologic Response Rates in Patients Who Failed Prior Combination Therapy with Certain Direct Acting Antiviral (DAA) Agents Results of C-SWIFT Study Provide Proof-of-Concept for Shorter Than Twelve Weeks Duration of Treatment with Triple-DAA Regimen in Patients with Chronic Hepatitis C Virus (HCV) Genotypes 1 and 3 Infection VIENNA April 25, 2015 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from two Phase 2 clinical trials evaluating the safety and efficacy of the companys investigational once-daily treatment regimen of grazoprevir (100mg) and elbasvir (50mg)[1] in adult patients with chronic hepatitis C virus (HCV) infection. Language: English read more
Tags: the
results
international
trial
Plan now to ensure you aren't caught out by liver fluke
2015-04-20 13:03:13| Livestock - Topix.net
Fluke is a huge burden to the livestock industry, in terms of loss of production as well as lost opportunities from the fifth quarter. EBLEX has estimated that liver fluke infections can reduce daily liveweight gains by up to 30% and infected cattle can take up to an extra 80 days to finish.
Tags: plan
ensure
caught
liver
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »